Summary

The global Sulfaguanidine API market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Sulfaguanidine is an orally active antimicrobial agent/antibiotic of sulfonamide class. Sulfaguanidine is poorly absorbed from the gut but is well suited for the treatment of bacillary dysentery and other enteric infections. A sulfanilamide antimicrobial agent that is used to treat enteric infections.
In 2025, the China Sulfaguanidine API market was US$ million, while the market stood at US$ million. China accounted for % of the global market in 2025 and for %. ’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Sulfaguanidine API include Wugan Pharmaceutical, Shouguang FuKang Pharmaceutical, Southwest Synthetic Pharmaceutical, Nanhai Beisha Pharmaceutical, Wujiang Bolin Industrial, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in China accounted for about % of the market in 2025, while the top three in held nearly %.
The global Sulfaguanidine API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Wugan Pharmaceutical
Shouguang FuKang Pharmaceutical
Southwest Synthetic Pharmaceutical
Nanhai Beisha Pharmaceutical
Wujiang Bolin Industrial
Segment by Type
Content ≥98%
Content ≥99%
Segment by Application
Human Drugs
Veterinary Drugs
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
China
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Sulfaguanidine API sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Sulfaguanidine API manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Sulfaguanidine API product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Sulfaguanidine API value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Sulfaguanidine API Product Scope
1.2 Sulfaguanidine API by Type
1.2.1 Global Sulfaguanidine API Sales by Type (2021, 2025 & 2032)
1.2.2 Content ≥98%
1.2.3 Content ≥99%
1.3 Sulfaguanidine API by Application
1.3.1 Global Sulfaguanidine API Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Human Drugs
1.3.3 Veterinary Drugs
1.4 Global Sulfaguanidine API Market Estimates and Forecasts (2021-2032)
1.4.1 Global Sulfaguanidine API Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Sulfaguanidine API Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Sulfaguanidine API Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Sulfaguanidine API Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Sulfaguanidine API Historical Market Scenario by Region (2021-2026)
2.2.1 Global Sulfaguanidine API Sales Market Share by Region (2021-2026)
2.2.2 Global Sulfaguanidine API Revenue Market Share by Region (2021-2026)
2.3 Global Sulfaguanidine API Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Sulfaguanidine API Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Sulfaguanidine API Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 China Sulfaguanidine API Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Sulfaguanidine API Historical Market Review by Type (2021-2026)
3.1.1 Global Sulfaguanidine API Sales by Type (2021-2026)
3.1.2 Global Sulfaguanidine API Revenue by Type (2021-2026)
3.1.3 Global Sulfaguanidine API Average Price by Type (2021-2026)
3.2 Global Sulfaguanidine API Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Sulfaguanidine API Sales Forecast by Type (2027-2032)
3.2.2 Global Sulfaguanidine API Revenue Forecast by Type (2027-2032)
3.2.3 Global Sulfaguanidine API Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Sulfaguanidine API
4 Global Market Size by Application
4.1 Global Sulfaguanidine API Historical Market Review by Application (2021-2026)
4.1.1 Global Sulfaguanidine API Sales by Application (2021-2026)
4.1.2 Global Sulfaguanidine API Revenue by Application (2021-2026)
4.1.3 Global Sulfaguanidine API Average Price by Application (2021-2026)
4.2 Global Sulfaguanidine API Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Sulfaguanidine API Sales Forecast by Application (2027-2032)
4.2.2 Global Sulfaguanidine API Revenue Forecast by Application (2027-2032)
4.2.3 Global Sulfaguanidine API Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Sulfaguanidine API Applications
5 Competition Landscape by Players
5.1 Global Sulfaguanidine API Sales by Player (2021-2026)
5.2 Global Top Sulfaguanidine API Players by Revenue (2021-2026)
5.3 Global Sulfaguanidine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Sulfaguanidine API revenue as of 2025
5.4 Global Sulfaguanidine API Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Sulfaguanidine API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Sulfaguanidine API, Product Type & Application
5.7 Global Key Manufacturers of Sulfaguanidine API, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 China Market: Players, Segments, Downstream and Major Customers
6.1.1 China Sulfaguanidine API Sales by Company
6.1.1.1 China Sulfaguanidine API Sales by Company (2021-2026)
6.1.1.2 China Sulfaguanidine API Revenue by Company (2021-2026)
6.1.2 China Sulfaguanidine API Sales Breakdown by Type (2021-2026)
6.1.3 China Sulfaguanidine API Sales Breakdown by Application (2021-2026)
6.1.4 China Sulfaguanidine API Major Customers
6.1.5 China Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Wugan Pharmaceutical
7.1.1 Wugan Pharmaceutical Company Information
7.1.2 Wugan Pharmaceutical Business Overview
7.1.3 Wugan Pharmaceutical Sulfaguanidine API Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Wugan Pharmaceutical Sulfaguanidine API Products Offered
7.1.5 Wugan Pharmaceutical Recent Development
7.2 Shouguang FuKang Pharmaceutical
7.2.1 Shouguang FuKang Pharmaceutical Company Information
7.2.2 Shouguang FuKang Pharmaceutical Business Overview
7.2.3 Shouguang FuKang Pharmaceutical Sulfaguanidine API Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Shouguang FuKang Pharmaceutical Sulfaguanidine API Products Offered
7.2.5 Shouguang FuKang Pharmaceutical Recent Development
7.3 Southwest Synthetic Pharmaceutical
7.3.1 Southwest Synthetic Pharmaceutical Company Information
7.3.2 Southwest Synthetic Pharmaceutical Business Overview
7.3.3 Southwest Synthetic Pharmaceutical Sulfaguanidine API Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Southwest Synthetic Pharmaceutical Sulfaguanidine API Products Offered
7.3.5 Southwest Synthetic Pharmaceutical Recent Development
7.4 Nanhai Beisha Pharmaceutical
7.4.1 Nanhai Beisha Pharmaceutical Company Information
7.4.2 Nanhai Beisha Pharmaceutical Business Overview
7.4.3 Nanhai Beisha Pharmaceutical Sulfaguanidine API Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Nanhai Beisha Pharmaceutical Sulfaguanidine API Products Offered
7.4.5 Nanhai Beisha Pharmaceutical Recent Development
7.5 Wujiang Bolin Industrial
7.5.1 Wujiang Bolin Industrial Company Information
7.5.2 Wujiang Bolin Industrial Business Overview
7.5.3 Wujiang Bolin Industrial Sulfaguanidine API Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Wujiang Bolin Industrial Sulfaguanidine API Products Offered
7.5.5 Wujiang Bolin Industrial Recent Development
8 Sulfaguanidine API Manufacturing Cost Analysis
8.1 Sulfaguanidine API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Sulfaguanidine API
8.4 Sulfaguanidine API Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Sulfaguanidine API Distributors List
9.3 Sulfaguanidine API Customers
10 Sulfaguanidine API Market Dynamics
10.1 Sulfaguanidine API Industry Trends
10.2 Sulfaguanidine API Market Drivers
10.3 Sulfaguanidine API Market Challenges
10.4 Sulfaguanidine API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer